Sex- Or Gender-Specific Differences In The Clinical Presentation, Outcome, And Treatment Of SARS-CoV-2

January 2021 in “ Clinical Therapeutics ”

Jeannette Wolfe, Basmah Safdar, Tracy E. Madsen, Kinjal Sethuraman, Bruce M. Becker, Marna Rayl Greenberg, Alyson J. McGregor

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on clinicaltherapeutics.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men

139 citations , December 2020 in “Cell Stem Cell”

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

research Are Sex Discordant Outcomes in COVID-19 Related to Sex Hormones?

42 citations , June 2020 in “Seminars in Oncology”

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

research Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'

119 citations , May 2020 in “Journal of The American Academy of Dermatology”

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

research Cutaneous Signs in COVID-19 Patients: A Review

176 citations , May 2020 in “Dermatologic Therapy”

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.